Minkoff

Along with so many in the field of managed care, the team at The American Journal of Managed Care® (AJMC®) was saddened to learn of the loss of our friend Neil Minkoff, MD, on May 4, 2022. For more than a decade, Dr Minkoff brought his knowledge and energy to a host of projects, the scope of which grew in diversity and complexity as our brand expanded into new areas. As AJMC® grew, so did Dr Minkoff’s role with us—he served as a writer, on-air host, trainer, and sounding board for ideas.
Dr Minkoff served as a moderator for more than a dozen AJMC® PeerExchange and Stakeholder Summit programs, which covered topics that ranged from multiple sclerosis to chronic obstructive pulmonary disease to cardiorenal metabolic syndrome. His versatility made him a go-to resource for discussions that traversed clinical and payer considerations, as he understood the points that our readers and listeners weighed in their decision-making.
Collaborations with AJMC® increased after April 2020, when Dr Minkoff joined COEUS Consulting as chief medical officer. A year later, Dr Minkoff and his COEUS colleagues addressed an important topic in reimbursement—how to pay for incredibly expensive, one-time treatments—when they published, “The Impact of Reinsurance of Gene Therapies on Employer Financial Risk,” in Evidence-Based Oncology™ (EBO).
Dr Minkoff was still collaborating with us when he died this spring. This summer, his colleagues at COEUS worked with the AJMC® editorial staff to complete a 2-part project on the future of telehealth, which appeared online and in this issue of EBO. Our deepest sympathies are extended to Dr Minkoff’s wife, Joyce, his family, his colleagues at COEUS Consulting, and to the many former colleagues and friends who were affected and saddened by his passing.
From everyone at The American Journal of Managed Care®

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis
February 6th 2026Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL measures into trials is urgently needed.
Read More
Building Trust: Public Priorities for Health Care AI Labeling
January 27th 2026A Michigan-based deliberative study found strong public support for patient-informed artificial intelligence (AI) labeling in health care, emphasizing transparency, privacy, equity, and safety to build trust.
Read More
Ambient AI Tool Adoption in US Hospitals and Associated Factors
January 27th 2026Nearly two-thirds of hospitals using Epic have adopted ambient artificial intelligence (AI), with higher uptake among larger, not-for-profit hospitals and those with higher workload and stronger financial performance.
Read More
Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions
January 26th 2026Skilled nursing facilities (SNFs) with a high volume of referred patients with Alzheimer disease and related dementias may work harder to manage care transitions with less availability of resources that enable high-quality handoffs.
Read More